Molly Yang

Head of Portfolio Management

2023 - Current

NZGCP is a New Zealand Government Fund which is invested through two vehicles, a $300 million Venture Capital Fund of funds and a $50 million angel seed Fund. I manage a diverse portfolio of technology companies, from seed stage to publicly listed, providing support and facilitating connections to drive their international growth. As a senior member of the investment team and a member of the investment committee, I play a key role in strategic decision-making.

Senior Portfolio Manager

2022 - 2022

Investment Manager

2015 - 2022

I am primary responsible for managing angel fund investments and also supporting venture capital fund of funds activities and performance monitoring. My main roles include new investment opportunity screening, due diligence, deal execution, divestment and portfolio management.

Board Observer

2024 - 2024

The Clinician is a leading digital health company that helps healthcare organisations globally to create more connected, convenient and patient-centred care pathways.

Startup Mentor

2024 - 2024

Supporting wahine and gender non-binary startup founders in Electrify Accelerator 2024.

Board Observer

2020 - 2022

A first-of-its-kind, cutting-edge tech company revolutionizing the world of insights with game-changing AI products.

Board Observer

2020 - 2022

Core Schedule is the leading provider of a suite of cloud-based work roster tools for staff in emergency departments, hospitals, medical training programs, and urgent care clinics in New Zealand, Australia, and the United States.

Board Advisor

2017 - 2019

New Zealand's first Chinese-led angel fund, aims to invest in high growth Kiwi start-up companies, helping them make the most of opportunities in China. I assisted Zino defining investment strategy in NZ and established connection in the local eco-system.

Investment Consultant

2014 - 2014

Worked on the preparation of raising a venture capital co-fund between New Zealand and Taiwan focused on healthcare opportunities of benefit to child health, being the government funds as cornerstone investors.

Senior Associate

2011 - 2013

AlphaBridge Group is a boutique investment firm dedicated in investment into healthcare, biotechnology and medical device sectors in China. I was worked on deal sourcing / screening, investment documentation, due diligence, financial analysis and post-investment management, including reporting, monitoring performance, support portfolio companies for overseas development, financial control and corporate governance.

Assoicate

2010 - 2011

Broad Resources is a Venture Capital firm that invests into high growth SMEs in China, with $250 million fund. I was dedicated on investment, assessment and management of pharmaceutical and biotechnology companies, with focus on funding, business development and strategic partnership.

Senior Analyst

2007 - 2009

Goshawk is a private equity firm with main source of capital from U.S. hedge fund investor. I worked on industry research & analysis, deal info preparation, due diligence and reporting.